T 1934/23 (Lenvatinib in combination with etoposide and ifosfamide/EISAI) of 10.07.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T193423.20250710
- Date of decision
- 10 July 2025
- Case number
- T 1934/23
- Petition for review of
- -
- Application number
- 16837150.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- LENVATINIB IN COMBINATION WITH ETOPOSIDE AND IFOSFAMIDE FOR USE IN TREATING A TUMOR
- Applicant name
- Eisai R&D Management Co., Ltd.
- Opponent name
- STADA Arzneimittel AG
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56RPBA_2020_Art_012(6)_(2020)_Sent_1Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Fresh ground of opposition - admitted (no)
Amendment after notification communication Article 15(1) RPBA - exceptional circumstances (no)
Inventive step - reasonable expectation of success (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The patent is revoked.